ArticleBMJ public health2025
Associations of age at menopause, bilateral oophorectomy, hysterectomy and hormone replacement therapy with glycaemia and risk of dementia: a study based on the population-based UK Biobank cohort.
Article in BMJ public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association between hysterectomy and dementia risk in Korean women aged 40-59: a nationwide retrospective cohort study.Obstetrics & gynecology science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Menopausal factors, including age at menopause, bilateral oophorectomy, hysterectomy and hormone replacement therapy (HRT), have been associated with dementia risk, which might be due to increased glucose levels after menopause. This study investigated the associations of these menopausal factors with glycaemia and dementia risk, and whether glycaemia mediates the association of menopausal factors with dementia risk. Methods: We used longitudinal data from the population-based UK Biobank cohort (n=147 119 women; mean±SD age 55.2±8.0 years at baseline). Menopausal status, bilateral oophorectomy, hysterectomy, HRT and age at natural menopause, surgery and HRT were self-reported. Glycaemia was measured with fasting plasma glucose and haemoglobin A1c (HbA1c) levels. Dementia diagnoses were ascertained from hospital records. Cox proportional hazards regression analyses tested the associations between menopausal factors, glycaemia and dementia risk. Causal mediation models were used to test mediation. Results: After a mean follow-up of 12.5±1.6 years, 1385 participants had incident dementia. Though there was a direct effect of bilateral oophorectomy, hysterectomy, lifetime HRT and age at natural menopause and surgery on fasting plasma glucose and HbA1c levels, only age at natural menopause (HR=0.97 (95% CI 0.96 to 0.99) per year and HR=1.31 (95% CI 1.08 to 1.60) for early natural menopause) and lifetime HRT in women with natural menopause (HR=1.13 (95% CI 1.00 to 1.27)) were associated with dementia risk. Causal mediation analyses showed that up to 4.7% of the total effect of age at natural menopause on dementia risk was mediated by HbA1c levels, while both fasting plasma glucose and HbA1c affected the increased dementia risk for lifetime HRT in women with natural menopause. Conclusions: We observed associations between bilateral oophorectomy, hysterectomy, lifetime HRT and age at natural menopause and surgery with glycaemia. An earlier age at natural menopause was associated with increased dementia risk, and HbA1c marginally mediated this association. Inconsistent associations between HRT and dementia risk require further research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.